The life sciences industry is undergoing rapid regulatory market and technology changes and consumers have higher expectations than ever before. It is estimated that only 48% of the people consider the pharma industry trustworthy, compared to other organizations at 71%. Pharmaceutical companies need to scale up rapidly to deliver the patient expected outcomes for sustaining in the market. They have been grappling with challenges like siloed patient data across multiple systems, lack of standardized approach to increase patient engagement, lack of collaborative work with HCPs, caregivers, and mixed expectations of pharma stakeholders – all of which contribute to fragmented communications with patients. One of the key questions posed by pharma leaders is if “digitization is the solution or is it part of the solution” to resolve these challenges.
At Hexaware, we see digital patient engagement as the catalyst in accelerating digital transformation across the pharma value chain. Delivering consistent service to patients and healthcare providers alike by making the best use of Industry 4.0 technology solutions is paramount in building trust and loyalty. By enabling increased adoption of digital technologies by patients and HCPs and risk management, pharmaceutical companies can reposition themselves from a product-centric to a patient-centric organization.
By leveraging disruptive technologies, we have developed the world’s first digital medicine system approved by the FDA in November 2017. The drug-device combination comprising of tablet embedded with an ingestible sensor plus a wearable sensor that records when the pill was taken optimizes patient-centric care and health outcomes. We have partnered with a leading global provider of advanced data analytics, technology solutions and contract services to the life sciences industry to develop a commercial operations product that would offer continuous data to downstream systems and across end-users, including sales reps, key account managers and medical science liaisons, enabling planning face-to-face or remote interactions and delivering on-demand content to HCPs. This commercial technology suite was selected by a pharma giant for deployment across 100+ countries and approximately 14,000 users. Hexaware’s homegrown patient engagement platform combines patient needs with an omnichannel engagement approach, transforming trial participants and trial personnel experience by keeping patients on protocols from start to finish, eliminating costly delays to missing data that can compromise the results and integrity of a study.
We bring in strong domain understanding and experience by working with the largest pharmaceutical companies in facilitating their digital transformation journey. With cutting-edge IT solutions for the pharmaceutical industry, expertise in fast-tracking cloud adoption, harnessing the power of data and automating business operations, we enable organizations to achieve radical performance breakthroughs and efficiencies.
Read this white paper to know if your current digital and CRM platform is equipped to deal with the new landscape and what pharma commercial leaders must do to respond to the challenges effectively.
( Mandatory field * )